{"id":54899,"date":"2023-03-16T12:03:14","date_gmt":"2023-03-16T11:03:14","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\/"},"modified":"2023-03-16T12:03:14","modified_gmt":"2023-03-16T11:03:14","slug":"exscientia-to-report-full-year-2022-financial-results-on-march-23-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\/","title":{"rendered":"Exscientia to Report Full Year 2022 Financial Results on March 23, 2023"},"content":{"rendered":"
\n

\nCompany to host conference call and webcast on March 23, 2023 at 12:30 p.m. GMT \/ 8:30 a.m. EDT<\/i>\n<\/p>\n

OXFORD, England–(BUSINESS WIRE)–Exscientia plc (Nasdaq: EXAI) will report financial results for the fourth quarter and full year ended December 31, 2022 on Thursday, March 23, 2023 before the open of U.S. markets. The Company will host a conference call and webcast at 12:30 p.m. GMT \/ 8:30 a.m. EDT to provide a business update and review financial results.\n<\/p>\n

<\/a><\/p>\n

\nA webcast of the live call can be accessed by visiting the \u201cInvestors and Media\u201d section of the Company\u2019s website at investors.exscientia.ai<\/a>. Alternatively, the live conference call can be accessed by dialing +1 (888) 330 3292 (U.S.), +44 203 433 3846 (U.K.), +1 (646) 960 0857 (International) and entering the conference ID: 8333895. A replay will be available for 90 days under “Events and Presentations\u201d in the \u201cInvestors and Media\u201d section of the Exscientia website<\/a>.\n<\/p>\n

\nAbout Exscientia<\/b>\n<\/p>\n

\nExscientia is an AI-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our internal pipeline is focused on leveraging our precision medicine platform in oncology, while our partnered pipeline broadens our approach to other therapeutic areas. By pioneering a new approach to medicine creation, we believe the best ideas of science can rapidly become the best medicines for patients.\n<\/p>\n

\nVisit us at https:\/\/www.exscientia.ai<\/a> or follow us on Twitter @exscientiaAI<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Relations Contact:<\/b>
Sara Sherman
\n
investors@exscientia.ai<\/a><\/p>\n

Media Contact:<\/b>
Oliver Stohlmann
\n
media@exscientia.ai<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Company to host conference call and webcast on March 23, 2023 at 12:30 p.m. GMT \/ 8:30 a.m. EDT OXFORD, England–(BUSINESS WIRE)–Exscientia plc (Nasdaq: EXAI) will report financial results for the fourth quarter and full year ended December 31, 2022 on Thursday, March 23, 2023 before the open of U.S. markets. The Company will host … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54899","6":"format-standard","7":"category-industry"},"yoast_head":"\nExscientia to Report Full Year 2022 Financial Results on March 23, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exscientia to Report Full Year 2022 Financial Results on March 23, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Company to host conference call and webcast on March 23, 2023 at 12:30 p.m. GMT \/ 8:30 a.m. EDT OXFORD, England–(BUSINESS WIRE)–Exscientia plc (Nasdaq: EXAI) will report financial results for the fourth quarter and full year ended December 31, 2022 on Thursday, March 23, 2023 before the open of U.S. markets. The Company will host ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-16T11:03:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230316005148\/en\/1739869\/21\/Exscientia_Logo_for_BW.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Exscientia to Report Full Year 2022 Financial Results on March 23, 2023\",\"datePublished\":\"2023-03-16T11:03:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\\\/\"},\"wordCount\":283,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230316005148\\\/en\\\/1739869\\\/21\\\/Exscientia_Logo_for_BW.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\\\/\",\"name\":\"Exscientia to Report Full Year 2022 Financial Results on March 23, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230316005148\\\/en\\\/1739869\\\/21\\\/Exscientia_Logo_for_BW.jpg\",\"datePublished\":\"2023-03-16T11:03:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230316005148\\\/en\\\/1739869\\\/21\\\/Exscientia_Logo_for_BW.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230316005148\\\/en\\\/1739869\\\/21\\\/Exscientia_Logo_for_BW.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Exscientia to Report Full Year 2022 Financial Results on March 23, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Exscientia to Report Full Year 2022 Financial Results on March 23, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\/","og_locale":"en_US","og_type":"article","og_title":"Exscientia to Report Full Year 2022 Financial Results on March 23, 2023 - Pharma Trend","og_description":"Company to host conference call and webcast on March 23, 2023 at 12:30 p.m. GMT \/ 8:30 a.m. EDT OXFORD, England–(BUSINESS WIRE)–Exscientia plc (Nasdaq: EXAI) will report financial results for the fourth quarter and full year ended December 31, 2022 on Thursday, March 23, 2023 before the open of U.S. markets. The Company will host ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-16T11:03:14+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230316005148\/en\/1739869\/21\/Exscientia_Logo_for_BW.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Exscientia to Report Full Year 2022 Financial Results on March 23, 2023","datePublished":"2023-03-16T11:03:14+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\/"},"wordCount":283,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230316005148\/en\/1739869\/21\/Exscientia_Logo_for_BW.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\/","url":"https:\/\/pharma-trend.com\/en\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\/","name":"Exscientia to Report Full Year 2022 Financial Results on March 23, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230316005148\/en\/1739869\/21\/Exscientia_Logo_for_BW.jpg","datePublished":"2023-03-16T11:03:14+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230316005148\/en\/1739869\/21\/Exscientia_Logo_for_BW.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230316005148\/en\/1739869\/21\/Exscientia_Logo_for_BW.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/exscientia-to-report-full-year-2022-financial-results-on-march-23-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Exscientia to Report Full Year 2022 Financial Results on March 23, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54899","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54899"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54899\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54899"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54899"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54899"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}